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The Authors Reply: Severe metabolic acidosis can 
generate detremental clinical effect such as cardiovascular 
depression and central nervous system dysfunction
1). It also 
disturbe important key enzymes’ activity
2). The effect of 
bocarbonate therapy aimed at correcting the pH, however, 
is controversial. Bicarbonate therapy produced CO2 and 
paradoxically lower the intracellular pH and cerebrospinal 
fluid pH
3, 4). Bicarbonate infusion is associated with an 
increased blood lactate levels
4). It might be also produce 
the volume expansion, hypernatremia and renbound 
alkalemia. The other buffer agents such as Carbicarb 
(Na2CO3 + NaHCO3) and THAM (Tris-hydroxymethyl 
aminomethane) are available, but these agents dose not 
imporving outcomes of metabolic acidosis
4). 
Therefore, recent articles and text books suggest that 
therapy is aimed at correction of the underlying disorder, 
volume depletion, and electrolyte imbalance
4-6). On 
condition that severe acidosis (pH < 7.1) and the patient 
is deteriorating rapidly, bicarbonate therapy can be 
considered.   
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To the Editor: In his review "Acid-Base Disorders in lCU 
Patients, Oh
1) writes in the summary on p 66 "The treat-
ment target … is not the acidosis, but the underlying 
condition causing acidosis". In contrast to this statement, 
Edge et al.
2) have concluded that the immediate cause 
of coma in patients with acidosis is the very low blood 
pH. The glycolytic enzyme phosphofructokinase is pH 
dependent, as its activity is decreasing with decreasing pH, 
and, thus, glucose utilization in brain cells is impaired
3). For 
the readers of "Electrolyte Blood Press" it would be perhaps 
interesting to know, why the author did not comment the 
paper of Edge et al.
2).
On p 69, the author writes "HCO3¯ therapy does not 
improve the outcome in diabetic ketoacidosis … " Life-
threatening is the most severe stage of diabetic ketoacidosis, 
coma. If the treatment of diabetic ketoacidotic coma 
included also infusions of alkalizing solutions, lethality was 
zero %, e g
4). Without alkalizing solutions, lethality was 
up to 100%, e g
5). Again, it would be perhaps interesting 
to know why the author did not comment the papers of 
Wagner et al.
4) and Basu et al.
5). 
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